6 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEdiabetic macular edemaActive, not recruitingPhase 32026-10-02NCT07449936
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edemaeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 22026-10-01NCT06962839
A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyGeographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 22026-09-30NCT06769048
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 32026-09-17NCT06373731
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degenerationeye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degenerationActive, not recruitingPhase 32026-06-01NCT06864988
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyGeographic Atrophy, age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 22026-05-14NCT06722157